NANOHMICS INC - THIS SMALL BUSINESS INNOVATION RESEARCH PHASE I PROPOSAL WILL FOCUS ON DEVELOPING A DEOXYRIBONUCLEIC ACID BASED BINDER OF NEUROTOXINS THAT ALSO CATALYZES DEACTIVATION OF THE AGENT, RENDERING IT INEFFECTIVE AS A WARFARE WEAPON.
Key Details
Description
THIS SMALL BUSINESS INNOVATION RESEARCH PHASE I PROPOSAL WILL FOCUS ON DEVELOPING A DEOXYRIBONUCLEIC ACID BASED BINDER OF NEUROTOXINS THAT ALSO CATALYZES DEACTIVATION OF THE AGENT, RENDERING IT INEFFECTIVE AS A WARFARE WEAPON.
Context & Analysis
On Nov 20, 2025, Department of Defense obligated $209,573.26 to NANOHMICS INC for this small business innovation research phase i proposal will focus on developing a deoxyribonucleic acid based binder of neurotoxins that also catalyzes deactivation of the agent, rendering it ineffe…. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources with 1 offer received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in AUSTIN, TX. This award is one of several similar procurements from Department of Defense under NAICS 541715 — related awards are listed below.
Contractor Information
Similar Awards
NAVAL NUCLEAR LABORATORY
FLUOR MARINE PROPULSION, LLC
$14.2B
NAVAL NUCLEAR LABORATORY
FLUOR MARINE PROPULSION, LLC
$13.6B
NEXT GENERATION OVERHEAD PERSISTENT INFRARED GEOSYNCHRONOUS EARTH ORBIT SPACE VEHICLE 1-3 PHASE 1
LOCKHEED MARTIN CORP
$6.3B
NEXT GENERATION OVERHEAD PERSISTENT INFRARED GEOSYNCHRONOUS EARTH ORBIT SPACE VEHICLE 1-3 PHASE 1
LOCKHEED MARTIN CORP
$6.3B
DESIGN, DEVELOPMENT, AND DEVELOPMENTAL TESTING OF THE NEXT GENERATION INTERCEPTOR (NGI) ALL-UP-ROUND (AUR)
LOCKHEED MARTIN CORPORATION
$4.6B
Stay Updated
Get notified about new opportunities matching your interests.